Evaluation System for the Efficacy of Immunologic Checkpoint Inhibitors in NSCLC

Clinical trial NCT04629027 · UNKNOWN

Trial details

NCT number: NCT04629027
Sponsor: Peking University Cancer Hospital & Institute
Status: UNKNOWN
Study type: OBSERVATIONAL

Non Small Cell Lung Cancer

Start date: 2021-03-03
Primary completion: 2023-05-30
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.